Related Experiment Video
Updated: Feb 21, 2026

07:17
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
1.9K
Untangling the Web of Lymphoma Somatic Mutations
1Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Cell
|October 7, 2017
Summary
Researchers characterized diffuse large B cell lymphomas (DLBCL) using genetic and clinical data. This study offers a comprehensive view of DLBCL biology, paving the way for precision medicine strategies.
Area of Science:
- Genetics
- Oncology
- Bioinformatics
Background:
- Diffuse large B cell lymphoma (DLBCL) is a significant hematologic malignancy.
- Understanding the molecular underpinnings of DLBCL is crucial for developing effective treatments.
Purpose of the Study:
- To provide a comprehensive genetic characterization of DLBCL.
- To integrate multi-omics data with clinical information for DLBCL.
- To establish a foundation for precision medicine in DLBCL.
Main Methods:
- Large-scale whole exome capture and sequencing.
- Transcriptome analysis.
- CRISPR screening.
- Integrative clinical biomarker studies.
Main Results:
- Detailed genetic landscape of DLBCL subtypes.
- Identification of key molecular drivers and pathways in DLBCL.
- Correlation of genetic profiles with clinical outcomes.
Conclusions:
- This study presents the first comprehensive genetic overview of DLBCL.
- The findings provide critical insights into DLBCL biology.
- This work lays the groundwork for future precision medicine approaches in DLBCL treatment.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Loss of Tumor Suppressor Gene Functions
6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K

